TRK-IN-17 is a potent inhibitor of TRK, specifically targeting tropomyosin-related kinase (Trk), a receptor tyrosine kinase activated by neurotrophic factors, which include nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophic factor-3 (NT-3), and neurotrophic factor-4/5 (NT-4/5). TRK-IN-17 has potential for cancer disease research.
Molekulargewicht:
441.5
CAS Nummer:
[2409544-80-3]
Formel:
C21H21F2N7S
Target-Kategorie:
Trk receptor|||Others
T62561
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten